Analysis Report on the North American 3D Printing Healthcare Market (2025-2033) Highlighting 3D Systems, Exone, Formlabs, General Electric, Materialise, Oxferd Performance Materials, and Organovo
Market Growth Projection: The North America 3D Printing in Healthcare Market is expected to grow from US$ 1.34 billion in 2024 to US$ 3.1 billion by 2033, with a CAGR of 9.75% driven by personalized medical solutions and advancements in biocompatible materials.
Key Applications and Innovations: Major applications include customized surgical models, implants, and prosthetics, with the U.S. leading due to its advanced healthcare system and regulatory support, fostering innovation in 3D printing technologies.
Challenges to Adoption: High initial costs and complex regulatory frameworks pose significant challenges to widespread adoption, particularly for smaller healthcare facilities, which may limit access to advanced 3D printing technologies.
Future Outlook: Despite challenges, the integration of machine learning and AI into 3D printing processes, along with the expiration of patents, is expected to enhance market growth and innovation in personalized healthcare solutions.
Trade with 70% Backtested Accuracy
Analyst Views on GE
About GE
About the author

GE Aerospace's Earnings Outlook Remains Positive Despite Margin Concerns
- Earnings Guidance: GE Aerospace's Q4 2025 earnings report implied that operating profit margins would remain flat compared to 2025, despite a projected low double-digit revenue growth in 2026, leading to a 1.68% drop in stock price as the market reacted negatively.
- Engine Sales Model: The core business involves designing and manufacturing commercial aircraft engines, where newly installed engines are often sold at a loss initially, but the lucrative aftermarket revenue from long-term service agreements is expected to support future profitability.
- Spare Engine Ratio Impact: As the supply chain crisis eases, airlines are reducing their spare engine ratios, with CFO Rahul Ghai indicating that margins are expected to remain flat in 2026, posing challenges to short-term profit outlook.
- Long-Term Profit Potential: Despite short-term margin pressures, management noted that GE engines maintain high utilization rates, with a projected retirement rate of 2% in 2026, suggesting that more older planes will continue to operate, which is beneficial for aftermarket sales growth.

GE Vernova Stock Surges 400% Post Spin-Off, But Is It Overvalued?
- Independent Business Performance: Since its spin-off from General Electric in April 2024, GE Vernova's stock has surged over 400%, reflecting strong market optimism about its standalone prospects, although its price-to-earnings ratio stands at 108, significantly above the industry average.
- Market Competitive Advantage: GE Vernova focuses on manufacturing large equipment for the electricity sector, such as natural gas and wind turbines, primarily serving electric utility companies, with long-term service contracts providing a stable income stream that enhances its competitive position.
- Future Growth Potential: As of Q3 2025, GE Vernova's backlog reached $135 billion, with expectations to grow to $200 billion by 2028, establishing a solid foundation for earnings growth over the next decade and highlighting its critical role in the transition to cleaner energy.
- Valuation Risk Warning: Despite GE Vernova's strong business outlook, its current high valuation may deter value investors, especially when compared to the average P/E of 26.5 for the industry and 38.6 for the tech sector, indicating that the stock may be overvalued by the market.






